Welcome to the Recombinant Antibody Network Portal
The Recombinant Antibody Network is a consortium of highly integrated technology centers at UCSF, the University of Chicago, and the University of Toronto, unified under a common goal to generate therapeutic grade recombinant antibodies at a proteome wide scale for biology and biomedicine.
Given that over half the human proteome is not annotated and that functional antibodies are not reliably available, a complete set of validated antibodies would greatly advance all areas of biology, including cancer therapy and infectious disease control. To undertake these challenges, RAN is systematically and comprehensively profiling families of protein targets using novel, modern high-throughput in vitro technology.
Redox-based reagents for chemoselective methionine bioconjugation. (published on 2017 Feb 10)
Fc Engineering for Developing Therapeutic Bispecific Antibodies and Novel Scaffolds. (published on 2017 Jan 26)